HEADER APOPTOSIS 17-JUN-15 5C3H TITLE FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF APOPTOSIS TITLE 2 PROTEINS: COMPOUND 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE XIAP; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 249-354; COMPND 5 SYNONYM: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4,IAP-LIKE COMPND 6 PROTEIN,HILP,INHIBITOR OF APOPTOSIS PROTEIN 3,HIAP3,X-LINKED COMPND 7 INHIBITOR OF APOPTOSIS PROTEIN,X-LINKED IAP; COMPND 8 EC: 6.3.2.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: XIAP, API3, BIRC4, IAP3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET 28B KEYWDS APOPTOSIS, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR G.CHESSARI,I.M.BUCK,J.E.H.DAY,P.J.DAY,A.IQBAL,C.N.JOHNSON,E.J.LEWIS, AUTHOR 2 V.MARTINS,D.MILLER,M.READER,D.C.REES,S.J.RICH,E.TAMANINI,M.VITORINO, AUTHOR 3 G.A.WARD,P.A.WILLIAMS,G.WILLIAMS,N.E.WILSHER,A.J.-A.WOOLFORD REVDAT 3 10-JAN-24 5C3H 1 REMARK REVDAT 2 09-SEP-15 5C3H 1 JRNL REVDAT 1 12-AUG-15 5C3H 0 JRNL AUTH G.CHESSARI,I.M.BUCK,J.E.DAY,P.J.DAY,A.IQBAL,C.N.JOHNSON, JRNL AUTH 2 E.J.LEWIS,V.MARTINS,D.MILLER,M.READER,D.C.REES,S.J.RICH, JRNL AUTH 3 E.TAMANINI,M.VITORINO,G.A.WARD,P.A.WILLIAMS,G.WILLIAMS, JRNL AUTH 4 N.E.WILSHER,A.J.WOOLFORD JRNL TITL FRAGMENT-BASED DRUG DISCOVERY TARGETING INHIBITOR OF JRNL TITL 2 APOPTOSIS PROTEINS: DISCOVERY OF A NON-ALANINE LEAD SERIES JRNL TITL 3 WITH DUAL ACTIVITY AGAINST CIAP1 AND XIAP. JRNL REF J.MED.CHEM. V. 58 6574 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26218264 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00706 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 8179 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.310 REMARK 3 FREE R VALUE TEST SET COUNT : 434 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.52 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2218 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2484 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2101 REMARK 3 BIN R VALUE (WORKING SET) : 0.2452 REMARK 3 BIN FREE R VALUE : 0.3039 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.28 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 117 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 866 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 67 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 79.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.81510 REMARK 3 B22 (A**2) : -5.81510 REMARK 3 B33 (A**2) : 11.63020 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.354 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.282 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.236 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.257 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.226 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 932 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1288 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 313 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 25 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 136 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 932 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 106 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1070 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.99 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|249 - A|354 } REMARK 3 ORIGIN FOR THE GROUP (A): -17.3703 -28.7623 -4.1320 REMARK 3 T TENSOR REMARK 3 T11: -0.0812 T22: 0.0024 REMARK 3 T33: -0.0980 T12: -0.0467 REMARK 3 T13: -0.0033 T23: -0.0528 REMARK 3 L TENSOR REMARK 3 L11: 4.8521 L22: 0.9275 REMARK 3 L33: 2.1254 L12: -0.5990 REMARK 3 L13: -0.0187 L23: -0.9922 REMARK 3 S TENSOR REMARK 3 S11: 0.0615 S12: -0.1648 S13: 0.1613 REMARK 3 S21: 0.1376 S22: -0.0499 S23: 0.0094 REMARK 3 S31: 0.0847 S32: 0.1386 S33: -0.0116 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5C3H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210965. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK 9.9 REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8179 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 28.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.200 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 2.060 REMARK 200 R MERGE (I) : 0.36800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2OPY REMARK 200 REMARK 200 REMARK: BLOCKS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES-NAOH 7.5, 3.9M NACL, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.86300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.43150 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 79.29450 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 52.86300 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 79.29450 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 26.43150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 245 REMARK 465 SER A 246 REMARK 465 HIS A 247 REMARK 465 MET A 248 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 352 6.81 -67.48 REMARK 500 VAL A 353 -57.98 -137.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 300 SG REMARK 620 2 CYS A 303 SG 105.2 REMARK 620 3 HIS A 320 NE2 97.1 113.9 REMARK 620 4 CYS A 327 SG 126.3 108.1 106.1 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4XE A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5C0K RELATED DB: PDB REMARK 900 5C0K AND 5C0L CONTAIN DIFFERENT LIGANDS BOUND TO THE SAME PROTEIN DBREF 5C3H A 249 354 UNP P98170 XIAP_HUMAN 249 354 SEQADV 5C3H GLY A 245 UNP P98170 EXPRESSION TAG SEQADV 5C3H SER A 246 UNP P98170 EXPRESSION TAG SEQADV 5C3H HIS A 247 UNP P98170 EXPRESSION TAG SEQADV 5C3H MET A 248 UNP P98170 EXPRESSION TAG SEQRES 1 A 110 GLY SER HIS MET ASN PHE PRO ASN SER THR ASN LEU PRO SEQRES 2 A 110 ARG ASN PRO SER MET ALA ASP TYR GLU ALA ARG ILE PHE SEQRES 3 A 110 THR PHE GLY THR TRP ILE TYR SER VAL ASN LYS GLU GLN SEQRES 4 A 110 LEU ALA ARG ALA GLY PHE TYR ALA LEU GLY GLU GLY ASP SEQRES 5 A 110 LYS VAL LYS CYS PHE HIS CYS GLY GLY GLY LEU THR ASP SEQRES 6 A 110 TRP LYS PRO SER GLU ASP PRO TRP GLU GLN HIS ALA LYS SEQRES 7 A 110 TRP TYR PRO GLY CYS LYS TYR LEU LEU GLU GLN LYS GLY SEQRES 8 A 110 GLN GLU TYR ILE ASN ASN ILE HIS LEU THR HIS SER LEU SEQRES 9 A 110 GLU GLU CYS LEU VAL ARG HET ZN A 401 1 HET 4XE A 402 37 HETNAM ZN ZINC ION HETNAM 4XE 4-[2-OXO-2-(PIPERIDIN-1-YL)ETHYL]PIPERAZIN-1-IUM FORMUL 2 ZN ZN 2+ FORMUL 3 4XE C11 H22 N3 O 1+ FORMUL 4 HOH *67(H2 O) HELIX 1 AA1 ASN A 259 ALA A 263 5 5 HELIX 2 AA2 ASP A 264 PHE A 270 1 7 HELIX 3 AA3 ASN A 280 ALA A 287 1 8 HELIX 4 AA4 ASP A 315 TYR A 324 1 10 HELIX 5 AA5 CYS A 327 LEU A 352 1 26 SHEET 1 AA1 3 PHE A 289 ALA A 291 0 SHEET 2 AA1 3 VAL A 298 CYS A 300 -1 O LYS A 299 N TYR A 290 SHEET 3 AA1 3 GLY A 306 LEU A 307 -1 O LEU A 307 N VAL A 298 LINK SG CYS A 300 ZN ZN A 401 1555 1555 2.25 LINK SG CYS A 303 ZN ZN A 401 1555 1555 2.31 LINK NE2 HIS A 320 ZN ZN A 401 1555 1555 2.16 LINK SG CYS A 327 ZN ZN A 401 1555 1555 2.35 SITE 1 AC1 4 CYS A 300 CYS A 303 HIS A 320 CYS A 327 SITE 1 AC2 7 GLY A 306 THR A 308 ASP A 309 TRP A 310 SITE 2 AC2 7 GLU A 314 GLN A 319 TRP A 323 CRYST1 71.562 71.562 105.726 90.00 90.00 90.00 P 41 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013974 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013974 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009458 0.00000